Related Experiment Video
Updated: Jan 21, 2026

Chronic Ovine Model of Right Ventricular Failure and Functional Tricuspid Regurgitation
Published on: March 17, 2023
Clinical predictors of marked improvement in left ventricular performance after cardiac resynchronization therapy in
Maurizio Mangiavacchi1, Maurizio Gasparini, Francesco Faletra
1Department of Cardiology, IRCCS Istituto Clinico Humanitas, Rozzano, Milan, Italy. maurizio.mangiavacchi@humanitas.it
Insights
Cardiac resynchronization therapy (CRT) improves heart function and exercise capacity. Nonischemic heart failure etiology is the key predictor of a significant positive response to CRT.
Area of Science:
- Cardiology
- Medical Devices
- Heart Failure Management
Background:
- Cardiac resynchronization therapy (CRT) is known to improve cardiac performance and reduce mortality.
- Identifying patients who will most benefit from CRT remains a clinical challenge.
- Predictive factors for optimal CRT outcomes require further elucidation.
Purpose of the Study:
- To identify pre-implantation characteristics that predict the best outcomes following CRT.
- To determine which patient subgroups experience the most significant benefits from CRT.
Main Methods:
- Observational study involving 156 patients undergoing CRT.
- Echocardiography and 6-minute walking tests were performed at baseline and 12 months post-CRT.
- Analysis of pre-implant characteristics to correlate with post-CRT outcomes.
Main Results:
- Significant improvements observed post-CRT: increased left ventricular ejection fraction (+29.6%), decreased end-systolic volume (-26.4%), reduced mitral regurgitation, and improved NYHA functional class.
- Exercise tolerance increased by 31.1% post-CRT.
- Nonischemic etiology of heart failure was the sole independent predictor of a marked increase in left ventricular ejection fraction; benefit inversely correlated with ischemic damage extent in ischemic cardiomyopathy.
Conclusions:
- CRT leads to long-term improvements in left ventricular function and exercise tolerance.
- Nonischemic cardiomyopathy etiology is the strongest predictor of a marked CRT response.
- Absence of nonviable scar tissue in nonischemic hearts likely contributes to better CRT outcomes.
Background:
Previous studies have shown that cardiac resynchronization therapy (CRT) improves cardiac performance and decreases mortality and hospital admission rates. However, it is not yet clear which patients will benefit from the procedure the most. The purpose of the study was to identify the pre-implant characteristics that better predict which patients will have the best outcome after CRT.
Methods:
In this observational study, 156 patients were studied with echocardiography and a 6-minute walking test at baseline and 12 months after CRT.
Results:
After CRT, we observed an increase in left ventricular ejection fraction (+29.6%, P < .0001), a decrease in left ventricular end systolic volume (-26.4%, P < .0001), in the proportion of patients with grade 2-4 mitral regurgitation (from 47.1% to 34.0%, P = .002), and with NYHA functional class III-IV (from 83.2% to 11.6%, P < .0001), an increase in exercise tolerance (+31.1%, P < .0001). Sixty-two patients had a marked increase in left ventricular ejection fraction (> 10 units); the only independent predictor of a marked effect of CRT was the nonischemic etiology of heart failure. In patients with ischemic cardiomyopathy, the benefit on ejection fraction correlates inversely with the extension of the ischemic damage.
Conclusions:
CRT improves left ventricular function and exercise tolerance in the long term. The nonischemic etiology of the cardiomyopathy is the only independent predictor of a marked effect of CRT; this is probably due to the absence of ischemic, nonviable scar tissue in these patients.
More Related Videos
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
07:24Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
Published on: April 8, 2013
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Heart Failure III: Clinical Manifestations
Heart Failure II: Pathophysiology
Heart Failure I: Introduction
Cardiac Catheterization III: Left Heart Catheterization
Pathophysiology of Heart Failure